Other grades of this product :
| PRT062607 (Hydrochloride) Basic information |
| Product Name: | PRT062607 (Hydrochloride) | | Synonyms: | PRT062607 (Hydrochloride);PRT062607 (P505-15, BIIB057) HCl;P505-15 hydrochloride;CS-995;BIIB057 HCl;4-((4-(2H-1,2,3-Triazol-2-yl)phenyl)amino)-2-(((1R,2S)-2-aminocyclohexyl)amino)pyrimidine-5-carboxamide hydrochloride;P505-15; PRT2607; PRT-2607; PRT 2607; PRT-062607; PRT 062607; P505-15; BIIB057;2-[[(1R,2S)-2-AMinocyclohexyl]aMino]-4-[[3-(2H-1,2,3-triazol-2-yl)phenyl]aMino]-5-pyriMidinecarboxaMide Hydrochloride | | CAS: | 1370261-97-4 | | MF: | C19H24ClN9O | | MW: | 429.90656 | | EINECS: | | Product Categories: | Inhibitors;Pharmaceuticals, Intermediates & Fine Chemicals | | Mol File: | 1370261-97-4.mol |
| PRT062607 (Hydrochloride) Chemical Properties |
| solubility | ≥21.5 mg/mL in DMSO; insoluble in EtOH; ≥83.2 mg/mL in H2O with gentle warming | | form | solid |
| PRT062607 (Hydrochloride) Usage And Synthesis |
| Uses | PRT062607 (Hydrochloride)acts as a novel spleen tyrosine kinase (syk) inhibitors used in the treatment of leukemia.
|
| PRT062607 (Hydrochloride) Preparation Products And Raw materials |
|